MXC ASX

MGC Pharmaceuticals Receives Regulatory Green Light for Cannabis Dementia Drug

The Australian Therapeutic Goods Administration (TGA) has granted key approvals to the ASX-listed biotech firm, MGC Pharmaceuticals (ASX: MXC), to begin Phase IIB clinical trials o...